Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Canadian Genomics R&D Initiative on AMR One Health -- Bacterial Isolates

PROVIDER: PRJNA1076250 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR24422400_1.fastq.gz	Fastqsanger.gz
	SRR24422400_2.fastq.gz	Fastqsanger.gz
	SRR24422401_1.fastq.gz	Fastqsanger.gz
	SRR24422401_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5749

Similar Datasets

Project description:Canadian Genomics R&D Initiative on AMR One Health -- Metagenomes

| PRJNA1139734 | ENA

Canadian Genomics R&D Initiative on AMR One Health -- Experimental

Project description:Canadian Genomics R&D Initiative on AMR One Health -- Experimental Genome sequencing and assembly

| PRJNA1143527 | ENA

Universal antimicrobial resistance detection from clinical bacterial isolates using proteomics

Project description:Antimicrobial resistance (AMR) is an increasing challenge for therapy and management of bacterial infections. Currently, antimicrobial resistance detection relies on phenotypic assays, which are performed independently of species identification. On the contrary, phenotypic prediction from molecular data using genomics is gaining interest in clinical microbiology and might become a serious alternative in the future. Although, in general protein analysis should be superior to genomics for phenotypic prediction, no untargeted proteomics workflow specifically related to AMR detection has been proposed so far. In this study, we present a universal proteomics workflow to detect the bacterial species and antimicrobial resistance related proteins in the absence of secondary antibiotic cultivation in less than 4 h from a primary culture. The method was validated using a sample cohort of 7 bacterial species and 11 AMR determinants represented by 13 protein isoforms which resulted in a sensitivity of 92 % (100 % with vancomycin inference) and a specificity of 100 % with respect to AMR determinants. This proof-of concept study demonstrates the high potential of untargeted proteomics for clinical microbiology.

2021-11-25 | PXD022425 | Pride

Project description:Network program AMR super bugs one health

| PRJNA1203380 | ENA

Project description:Network program AMR super bugs one health

| PRJNA1207229 | ENA

Project description:Network program AMR super bugs one health

| PRJNA1202404 | ENA

Project description:Network program on AMR, superbugs and One health

| PRJNA1109570 | ENA

Project description:One-health Escherichia coli isolates

| PRJNA1166141 | ENA

Project description:Bacterial isolates recovered from the One Health project in Brazil

| PRJNA888994 | ENA

The cyclic-AMP binding domain of the efflux pump Rv3728 acts as a regulator of phosphatidyl-myo-inositol mannosides composition in Mycobacterium tuberculosis

Project description:Tuberculosis (TB) is an ancient disease caused by the intracellular bacterial pathogen Mycobacterium tuberculosis (Mtb). The rise of antimicrobial resistance (AMR) threatens to bring Mtb to the forefront of bacterial pathogens as the current treatments are increasingly becoming ineffective. Understanding the development of AMR and the virulence processes of Mtb is crucial for the identification of new drug targets and the rational design of anti-TB treatments. One of the established mechanisms of resistance is through the function of efflux proteins, which are transmembrane transporters that bind and remove antibiotic molecules out from the cell. Here, we determine the role of Rv3728, a major facilitator superfamily (MFS) efflux pump protein, which also predicted to bind 3',5'-cyclic adenosine monophosphate (cAMP). Using bioinformatic tools and cAMP binding assay, we confirm that Rv3728 binds to cAMP and identified E597 and R606 as important residues involved in binding. Although Rv3728 deletion has no impact on bacterial resistance and tolerance to different antibiotics, it affects membrane permeability and alters the acylation profile of phosphatidyl-myo-inositol mannosides lipids.

2024-06-10 | GSE268977 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data